Skip to content

S. 289 · 118th Congress (2023–2025)

Genomics Data Security Act

This bill establishes requirements and otherwise directs the National Institutes of Health (NIH) to take actions to address national security concerns in genomic and other research.

Specifically, the bill prohibits the use of NIH funds by any Chinese company (or its subcontractors or subsidiaries). This includes companies (1) over which the Chinese government, a Chinese national, or an entity organized under Chinese law exercises control; or (2) in which the Chinese government has a substantial interest. It also requires, as a condition of certification, that clinical laboratories that have access to U.S. health data disclose ties to the Chinese government.

In addition, the NIH must incorporate national security issues in its strategic plan and report annually on any improperly disclosed, vetted, or approved ties that NIH-funded researchers have to foreign governments.

Furthermore, the Department of Health and Human Services must establish a working group to update the NIH's Genomic Data Sharing Policy with respect to intellectual property, national security, and privacy concerns.

Show official title

A bill to improve national security at the National Institutes of Health, to address national security issues in the licensure of biological products, to address national security considerations in research at the Department of Health and Human Services, and for other purposes.

Expired in Senate committee

Derived from the legislative history, not an official disposition.

Latest actionReferred to committee

This bill’s path

This is S. 289’s recorded path, not a universal congressional workflow.

How bills become lawAll actions
  1. Introduced

  2. Passed Senate

  3. Passed House

  4. Sent to President

  5. Signed into law

  6. Expired

Sponsor
Sen. Marco Rubio (R-FL)
Policy area
Health
Subjects
  • Asia
  • China
  • Congressional oversight
  • Department of Health and Human Services
  • Executive agency funding and structure
  • Genetics
  • Government studies and investigations
  • Health facilities and institutions
  • 13 more
    • Health information and medical records
    • Health programs administration and funding
    • Health promotion and preventive care
    • Higher education
    • Intellectual property
    • International organizations and cooperation
    • Licensing and registrations
    • Medical ethics
    • Medical research
    • Medical tests and diagnostic methods
    • National Institutes of Health (NIH)
    • Research administration and funding
    • Research ethics

On this page

Timeline

i

In chronological order. Major procedural acts are shown in full. Committee work and ordinary amendments fold in place where they happened, so they do not jump the sequence or stretch the timeline.

  1. Introduced in Senate

    Document: Introduced in Senate

    Sources
  2. Latest

    Referred to committee

    Read twice and referred to the Committee on Health, Education, Labor, and Pensions.

    Sources
  3. Expired

    Introduced → Referred to Senate Health, Education, Labor, and Pensions → No further action before the 118th Congress ended.

Committees

  1. SenateHealth, Education, Labor, and PensionsReferred Feb 7, 2023

Text & titles

i

Each distinct name Congress.gov recorded, once. Official, short, display, and popular titles stay distinct when the wording differs. The same wording is not repeated for every text version.

Text versions
VersionDateLinks
Introduced in Senate
Titles (2)
  1. Genomics Data Security Act

    Display title, Short title · Introduced in Senate

  2. A bill to improve national security at the National Institutes of Health, to address national security issues in the licensure of biological products, to address national security considerations in research at the Department of Health and Human Services, and for other purposes.

    Official title · Introduced in Senate